Selinexor and Radiation Therapy Trial for DIPG and HGG Shows Promise
A phase I/II trial is evaluating the safety and efficacy of selinexor combined with radiation therapy in children with DIPG and HGG.
Asset / Drug
Drug and asset intelligence for Selinexor with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.